Dr. Sati Sian, Agilio Chairman, and Neil Laycock, Agilio CEO.
(L - R): Dr. Sati Sian, Agilio Chairman, and Neil Laycock, Agilio CEO.

Sheffield based frontline healthcare software provider to expand with new investment

Agilio, a UK frontline healthcare operations software provider, today announced a strategic growth investment from Five Arrows, the alternative assets arm of Rothschild & Co., and TA Associates, a leading global private equity firm, to support the next phase of the Company’s ‘ambitious’ expansion plans.

Agilio offers a comprehensive suite of best-of-breed products that help healthcare professionals automate and optimise critical operational functions, such as workforce management, compliance and clinical assets tracking. 

Since its founding in 2019, the Company has established itself as a market leader in the UK dental and primary care sectors, with many of the top 10 dental groups and Integrated Care Board areas using an Agilio system to enhance operations, drive productivity and increase efficiency.

Dr. Sati Sian, Agilio Chairman, commented: “In the four years since our inception, with support from founding investor August Equity, we have realised our vision of introducing professional, integrated solutions into frontline healthcare settings.

“We are now ready to scale up further and are delighted to welcome two world-class investors in the form of Five Arrows and TA to support us on the next stage of our journey.”

Neil Laycock, Agilio CEO, added: “Our user-friendly, integrated systems are helping thousands of under-pressure frontline healthcare providers work more efficiently every day. 

“This partnership with Five Arrows and TA will help us deliver new products and services for our core UK and Netherlands markets as we continue to expand into new customer sectors. We also plan to expand into multiple new countries where we believe there is strong demand for our solutions.”

Both TA and Five Arrows have global expertise and a proven track record of successfully scaling healthcare technology companies. Their investment will support Agilio to:

  • Bolster product development and innovation, enhancing value for its customers.
  • Expand into new verticals beyond primary care, dental and veterinary.
  • Accelerate international growth, following its first expansion into Europe with an acquisition in the Netherlands in 2022.

Naveen Wadhera, Managing Director at TA, concluded: “We have tracked Agilio for several years and have been deeply impressed by the Company’s journey thus far. 

“Through several strategic acquisitions and a continued commitment to innovation, Agilio has built a market-leading software platform that improves patient care and meets the evolving needs of healthcare providers.”

Our Partners